These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 22208729)

  • 41. P450(BM3) (CYP102A1): connecting the dots.
    Whitehouse CJ; Bell SG; Wong LL
    Chem Soc Rev; 2012 Feb; 41(3):1218-60. PubMed ID: 22008827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A highly active single-mutation variant of P450BM3 (CYP102A1).
    Whitehouse CJ; Bell SG; Yang W; Yorke JA; Blanford CF; Strong AJ; Morse EJ; Bartlam M; Rao Z; Wong LL
    Chembiochem; 2009 Jul; 10(10):1654-6. PubMed ID: 19492389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biotransformation of beta-ionone by engineered cytochrome P450 BM-3.
    Urlacher VB; Makhsumkhanov A; Schmid RD
    Appl Microbiol Biotechnol; 2006 Mar; 70(1):53-9. PubMed ID: 16001257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculations.
    Capoferri L; Leth R; ter Haar E; Mohanty AK; Grootenhuis PD; Vottero E; Commandeur JN; Vermeulen NP; Jørgensen FS; Olsen L; Geerke DP
    Proteins; 2016 Mar; 84(3):383-96. PubMed ID: 26757175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human P450-like oxidation of diverse proton pump inhibitor drugs by 'gatekeeper' mutants of flavocytochrome P450 BM3.
    Butler CF; Peet C; McLean KJ; Baynham MT; Blankley RT; Fisher K; Rigby SE; Leys D; Voice MW; Munro AW
    Biochem J; 2014 Jun; 460(2):247-59. PubMed ID: 24588219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Engineering the substrate specificity of Bacillus megaterium cytochrome P-450 BM3: hydroxylation of alkyl trimethylammonium compounds.
    Oliver CF; Modi S; Primrose WU; Lian LY; Roberts GC
    Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):537-44. PubMed ID: 9359427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytochrome P450 catalyzed oxidative hydroxylation of achiral organic compounds with simultaneous creation of two chirality centers in a single C-H activation step.
    Roiban GD; Agudo R; Reetz MT
    Angew Chem Int Ed Engl; 2014 Aug; 53(33):8659-63. PubMed ID: 24590553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crystallographic insights into a cobalt (III) sepulchrate based alternative cofactor system of P450 BM3 monooxygenase.
    Panneerselvam S; Shehzad A; Mueller-Dieckmann J; Wilmanns M; Bocola M; Davari MD; Schwaneberg U
    Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):134-140. PubMed ID: 28739446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
    Peters MW; Meinhold P; Glieder A; Arnold FH
    J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First steps towards a Zn/Co(III)sep-driven P450 BM3 reactor.
    Zhao L; Güven G; Li Y; Schwaneberg U
    Appl Microbiol Biotechnol; 2011 Aug; 91(4):989-99. PubMed ID: 21562982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
    Udit AK; Arnold FH; Gray HB
    J Inorg Biochem; 2004 Sep; 98(9):1547-50. PubMed ID: 15337607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Desaturation of alkylbenzenes by cytochrome P450(BM3) (CYP102A1).
    Whitehouse CJ; Bell SG; Wong LL
    Chemistry; 2008; 14(35):10905-8. PubMed ID: 19003834
    [No Abstract]   [Full Text] [Related]  

  • 53. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
    Urlacher VB; Schmid RD
    Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
    [No Abstract]   [Full Text] [Related]  

  • 54. P450 BM3-Catalyzed Regio- and Stereoselective Hydroxylation Aiming at the Synthesis of Phthalides and Isocoumarins.
    Holec C; Hartrampf U; Neufeld K; Pietruszka J
    Chembiochem; 2017 Apr; 18(7):676-684. PubMed ID: 28107587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combinatorial alanine substitution enables rapid optimization of cytochrome P450BM3 for selective hydroxylation of large substrates.
    Lewis JC; Mantovani SM; Fu Y; Snow CD; Komor RS; Wong CH; Arnold FH
    Chembiochem; 2010 Dec; 11(18):2502-5. PubMed ID: 21108271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tryptophan-96 in cytochrome P450 BM3 plays a key role in enzyme survival.
    Ravanfar R; Sheng Y; Gray HB; Winkler JR
    FEBS Lett; 2023 Jan; 597(1):59-64. PubMed ID: 36250256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.
    Kim DH; Kim KH; Kim DH; Liu KH; Jung HC; Pan JG; Yun CH
    Drug Metab Dispos; 2008 Nov; 36(11):2166-70. PubMed ID: 18669587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein and electrode engineering for the covalent immobilization of P450 BMP on gold.
    Ferrero VE; Andolfi L; Di Nardo G; Sadeghi SJ; Fantuzzi A; Cannistraro S; Gilardi G
    Anal Chem; 2008 Nov; 80(22):8438-46. PubMed ID: 18947200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Laboratory evolution of P450 BM3 for mediated electron transfer yielding an activity-improved and reductase-independent variant.
    Nazor J; Dannenmann S; Adjei RO; Fordjour YB; Ghampson IT; Blanusa M; Roccatano D; Schwaneberg U
    Protein Eng Des Sel; 2008 Jan; 21(1):29-35. PubMed ID: 18093991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Site-directed mutagenesis of the putative distal helix of peroxygenase cytochrome P450.
    Matsunaga I; Ueda A; Sumimoto T; Ichihara K; Ayata M; Ogura H
    Arch Biochem Biophys; 2001 Oct; 394(1):45-53. PubMed ID: 11566026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.